This federal contract award, identified as SPE2DB22D3016|SPE2DB25FADG9, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,671.20 firm fixed-price delivery order is for the supply of EMGALITY 120 MG/ML PENML, a pharmaceutical product. This contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, covering critical medical commodities across multiple therapeutic areas.
Generated 2/13/25, 9:12 AM